LVTX - LAVA Therapeutics GAAP EPS of -$0.24 beats by $0.18
2024-03-21 12:17:05 ET
More on LAVA Therapeutics
- Lava gets $7M from Pfizer as trial for cancer drug advances
- LAVA stock rises on clinical trial collaboration with Merck
- Seeking Alpha’s Quant Rating on LAVA Therapeutics
- Historical earnings data for LAVA Therapeutics
- Financial information for LAVA Therapeutics